FilingReader Intelligence
SSY Group receives approvals for key drug productions
June 12, 2025 at 05:07 PM UTC•By FilingReader AI
SSY Group Limited (HKEX:2005) announced that it has secured approvals for drug production and registration for Tranexamic Acid and Sodium Chloride Injection (100ml) from the National Medical Products Administration of China (NMPA). Classified as a type 3 chemical drug, this injection is primarily used for treating bleeding caused by acute or chronic hyperfibrinolysis.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:2005•Hong Kong Exchange
News Alerts
Get instant email alerts when SSY Group publishes news
Free account required • Unsubscribe anytime